63
Pharma & HealthcareBuy
Mirae Asset Healthcare
Mirae Asset · Direct–Growth · rank #5 of 18 by Smart Score
Trailing returns
1 Year
13.3%
+12.8% vs index
3 Years
24.6%
+12.3% vs index
5 Years
15.5%
+3.6% vs index
Since launch
22.1%
Year-by-year performance
2021
+28.6%-2.1% vs index
2022
-10.5%-14.3% vs index
2023
+36.1%+9.5% vs index
2024
+41.2%+25.6% vs index
2025
-2.0%-9.7% vs index
2026
+17.1%+18.8% vs index
Why this score
Mirae Asset Healthcare scores 63/100 — #5 of 18 Pharma & Healthcare fund (Buy). It stands out for expense ratio and 3y return — beating 97% of peers on expense ratio. The main drag is its volatility (better than only 15% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Expense ratio0.62% · 97th percentile in category
Volatility16.93 · 15th percentile in category
3Y return24.55% · 65th percentile in category
Sharpe ratio1.17 · 74th percentile in category
5Y return15.54% · 61st percentile in category
Fund size3252.55 Cr · 75th percentile in category